Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era

Clinical Transplantation

Volumn 20, Issue SUPPL. 15, 2006, Pages 16-19

  Okamoto, Masahiko ^a   Akioka, Kiyokazu ^b   Ushigome, Hidetaka ^b   Higuchi, Atsushi ^b   Nobori, Shuji ^b   Ogino, Shiro ^b   Uryuhara, Kenji ^a   Kaihara, Satoshi ^b   Hatta, Tsuguru ^b   Urasaki, Koji ^b   Yoshimura, Norio ^a,b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Calcineurin inhibitor; Kidney transplantation; Nephrotoxicity

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADOLESCENT; ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DRUG DOSE REGIMEN; FIBROSING ALVEOLITIS; FIBROSIS; FOLLOW UP; GLOMERULOPATHY; GRAFT SURVIVAL; HUMAN; HYALINE DEGENERATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; LONGITUDINAL STUDY; NEPHROTOXICITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; TISSUE INJURY; TISSUE SECTION;

ADULT; BIOPSY; CALCINEURIN; CYCLOSPORINE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; TACROLIMUS;

EID: 33746407688     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00544.x     Document Type: Article

References (8)

1. Yasumura T, Ohmori Y, Aikawa I et al. Improved outcome of renal transplantation with cyclosporine compared with azathioprine - experience in 33 recipients followed for over one year. Jpn J Surg 1986; 16: 181.
2. Okamoto M, Akioka K, Higuchi A et al. Clinicopathological evaluation of renal allograft treated with anti-CD25 monoclonal antibody. Clin Transplant 2005: 19 (Suppl. 14): 49.
3. Thervet E, Morelon E, Ducloux D et al. Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion. Clin Transplant 2000; 14: 561.
4. Ruiz JC, Campistol JM, Grinyo JM et al. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions. Transplantation 2004; 78: 1312.
5. Pilmore HL, Dittmer ID. Calcineurin inhibitor nephrotoxicity: Reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy. Clin Transplant 2002: 16: 191.
6. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 2004: 78: 557.
7. Sommerer C, Hergesell O, Nahm AM et al. Cyclosporin A toxicity of the renal allograft-a late complication and potentially reversible. Nephron 2002: 92: 339.
8. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group. Transplantation 1998: 66: 1736.